All content is current as of November 26, 2025, and subject to change based on regulatory developments, market conditions, and program updates
If accepted to the program, you will receive an email with instructions to set up your account and sign the contract
Tian D, Stoppel LJ, Heynen AJ, Lindemann L, Jaeschke G, Mills AA, et al
Cartwright MJ, Tchkonia T, Kirkland JL
Important Safety Considerations Semaglutide is not recommended for those with (Kommu & Whitfield, 2024) : Personal/family history of medullary thyroid carcinoma MEN2 Previous pancreatitis It can also increase the risk of hypoglycemia when used with insulin or sulfonylureas(Kommu & Whitfield, 2024)
Neuropharmacology (2015) 97:4657.10.1016/j.neuropharm.2015.04.037 55 ShihR-HWangC-YYangC-M